Ironwood Pharmaceuticals
IRWD
IRWD
162 hedge funds and large institutions have $2.5B invested in Ironwood Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less funds holding
Funds holding: 163 → 162 (-1)
22% less call options, than puts
Call options by funds: $2.28M | Put options by funds: $2.94M
Holders
162
Holding in Top 10
4
Calls
$2.28M
Puts
$2.94M
Top Buyers
| 1 | +$193M | |
| 2 | +$86.9M | |
| 3 | +$31M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.8M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$22.7M |
Top Sellers
| 1 | -$76.9M | |
| 2 | -$18M | |
| 3 | -$11.1M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$7.25M |
| 5 |
BM
Bridger Management
New York
|
-$5.3M |